Fundraising FoxLightstone Ventures — 2023 Investments
5 investments dated 2023 · listed companies and verified rows first · show all
65LAB accelerates drug discovery and therapeutic company formation by connecting academic research institutions, life science investors, and Evotec to develop novel medicines into commercial entities.
BiotechDeep TechSingapore, SG
BoardSteve Courtney(Expert in Residence)
Co-investorsClavystBioLeaps by Bayer
FIRE1 develops NORM, an implantable sensor placed in the inferior vena cava to directly measure fluid volume in heart failure patients, paired with a self-management platform to help patients engage with their own care.
Digital HealthHardwareMedical DevicesDublin, IE
Co-investorsAndera PartnersGimvIreland Strategic Investment FundLongitude CapitalNew Enterprise Associates (NEA)Seventure Partners+5 more
Tagworks Pharmaceuticals develops cancer therapies using its Click-to-Release platform, a chemical reaction that activates antibody-drug conjugates (ADCs), masked immunomodulators, and other prodrugs on-target while deactivating radioimmunotherapies off-target.
BiotechHealthtechMedical DevicesNijmegen, NL
Co-investorsBifNew Enterprise Associates (NEA)Novartis Venture FundYsios CapitalClarus VenturesGilde Healthcare+1 more
Willow (originally founded as Contento) offers social media management for small and medium-sized B2B professional service providers, combining a scheduling and content platform with AI tools and human social media coaching.
AI & Machine LearningEnterprise SoftwareMarketing TechSaaSGhent, BE
Ludwig Dumont(Founder)in
Co-investorsPMVSmartFinimec.istartHetz VenturesMeritech Capital PartnersNew Enterprise Associates (NEA)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.